Departement
Klinische Forschung
Achtung: Diese Seite kann nur von Administratoren besucht werden, da Sie nicht freigeschalten wurde.
Zurück
Publications Schmidt André

Association of Structural Magnetic Resonance Imaging Measures with Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis

Jalbrzikowski M.; Hayes R.A.; Wood S.J.; Nordholm D.; Zhou J.H.; Fusar-Poli P.; Uhlhaas P.J.; Takahashi T.; Sugranyes G.; Kwak Y.B.; Mathalon D.H.; Katagiri N.; Hooker C.I.; Smigielski L.; Colibazzi T.; Via E.; Tang J.; Koike S.; Rasser P.E.; Michel C.; Lebedeva I.; Hegelstad W.T.V.; De La Fuente-Sandoval C.; Waltz J.A.; Mizrahi R.; Corcoran C.M.; Resch F.; Tamnes C.K.; Haas S.S.; Lemmers-Jansen I.L.J.; Agartz I.; Allen P.; Amminger G.P.; Andreassen O.A.; Atkinson K.; Bachman P.; Baeza I.; Baldwin H.; Bartholomeusz C.F.; Borgwardt S.; Catalano S.; Chee M.W.L.; Chen X.; Cho K.I.K.; Cooper R.E.; Cropley V.L.; Dolz M.; Ebdrup B.H.; Fortea A.; Glenthoj L.B.; Glenthoj B.Y.; De Haan L.; Hamilton H.K.; Harris M.A.; Haut K.M.; He Y.; Heekeren K.; Heinz A.; Hubl D.; Hwang W.J.; Kaess M.; Kasai K.; Kim M.; Kindler J.; Klaunig M.J.; Koppel A.; Kristensen T.D.; Kwon J.S.; Lawrie S.M.; Lee J.; Leon-Ortiz P.; Lin A.; Loewy R.L.; Ma X.; McGorry P.; McGuire P.; Mizuno M.; Moller P.; Moncada-Habib T.; Munoz-Samons D.; Nelson B.; Nemoto T.; Nordentoft M.; Omelchenko M.A.; Oppedal K.; Ouyang L.; Pantelis C.; Pariente J.C.; Raghava J.M.; Reyes-Madrigal F.; Roach B.J.; Rossberg J.I.; Rossler W.; Salisbury D.F.; Sasabayashi D.; Schall U.; Schiffman J.; Schlagenhauf F.; Schmidt A.; Sorensen M.E.; Suzuki M.; Theodoridou A.; Tomyshev A.S.; Tor J.; Vaernes T.G.; Velakoulis D.; Venegoni G.D.; Vinogradov S.; Wenneberg C.; Westlye L.T.; Yamasue H.; Yuan L.; Yung A.R.; Van Amelsvoort T.A.M.J.; Turner J.A.; Van Erp T.G.M.; Thompson P.M.; Hernaus D.. JAMA psychiatry. 2021.

Brain volume changes after long-term injectable opioid treatment: A longitudinal voxel-based morphometry study

Schmidt A.; Vogel M.; Baumgartner S.; Wiesbeck G.A.; Lang U.; Borgwardt S.; Walter M.. Addiction biology. 2021.

Classification of first-episode psychosis using cortical thickness: A large multicenter MRI study

Pigoni A.; Dwyer D.; Squarcina L.; Borgwardt S.; Crespo-Facorro B.; Dazzan P.; Smesny S.; Spaniel F.; Spalletta G.; Sanfelici R.; Antonucci L.A.; Reuf A.; Oeztuerk O.F.; Schmidt A.; Ciufolini S.; Schonborn-Harrisberger F.; Langbein K.; Gussew A.; Reichenbach J.R.; Zaytseva Y.; Piras F.; Delvecchio G.; Bellani M.; Ruggeri M.; Lasalvia A.; Tordesillas-Gutierrez D.; Ortiz V.; Murray R.M.; Reis-Marques T.; Di Forti M.; Koutsouleris N.; Brambilla P.. European Neuropsychopharmacology. 2021.

Functional brain network dysfunctions in subjects at high-risk for psychosis: A meta-analysis of resting-state functional connectivity

Del Fabro L.; Schmidt A.; Fortea L.; Delvecchio G.; D'Agostino A.; Radua J.; Borgwardt S.; Brambilla P.. Neuroscience and biobehavioral reviews. 2021.

Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach.

Lalousis PA; Wood SJ; Schmaal L; Chisholm K; Griffiths SL; Reniers RLEP; Bertolino A; Borgwardt S; Brambilla P; Kambeitz J; Lencer R; Pantelis C; Ruhrmann S; Salokangas RKR; Schultze-Lutter F; Bonivento C; Dwyer D; Ferro A; Haidl T; Rosen M; Schmidt A; Meisenzahl E; Koutsouleris N; Upthegrove R; PRONIA Consortium.. Schizophrenia Bulletin. 2021.

Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression.

Koutsouleris N; Dwyer DB; Degenhardt F; Maj C; Urquijo-Castro MF; Sanfelici R; Popovic D; Oeztuerk O; Haas SS; Weiske J; Ruef A; Kambeitz-Ilankovic L; Antonucci LA; Neufang S; Schmidt-Kraepelin C; Ruhrmann S; Penzel N; Kambeitz J; Haidl TK; Rosen M; Chisholm K; Riecher-Rössler A; Egloff L; Schmidt A; Andreou C; Hietala J; Schirmer T; Romer G; Walger P; Franscini M; Traber-Walker N; Schimmelmann BG; Flückiger R; Michel C; Rössler W; Borisov O; Krawitz PM; Heekeren K; Buechler R; Pantelis C; Falkai P; Salokangas RKR; Lencer R; Bertolino A; Borgwardt S; Noethen M; Brambilla P; Wood SJ; Upthegrove R; Schultze-Lutter F; Theodoridou A; Meisenzahl E; PRONIA Consortium.. JAMA psychiatry. 2021.

Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Hauke DJ; Schmidt A; Studerus E; Andreou C; Riecher-Rössler A; Radua J; Kambeitz J; Ruef A; Dwyer DB; Kambeitz-Ilankovic L; Lichtenstein T; Sanfelici R; Penzel N; Haas SS; Antonucci LA; Lalousis PA; Chisholm K; Schultze-Lutter F; Ruhrmann S; Hietala J; Brambilla P; Koutsouleris N; Meisenzahl E; Pantelis C; Rosen M; Salokangas RKR; Upthegrove R; Wood SJ; Borgwardt S; PRONIA Group.. Translational Psychiatry. 2021.

Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysis.

Schaub AC; Kirschner M; Schweinfurth N; Mählmann L; Kettelhack C; Engeli EE; Doll JPK; Borgwardt S; Lang UE; Kaiser S; Walter M; Herdener M; Wrege J; Schmidt A. NeuroImage. Clinical. 2021.

Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum.

Kirschner M; Schmidt A; Hodzic-Santor B; Burrer A; Manoliu A; Zeighami Y; Yau Y; Abbasi N; Maatz A; Habermeyer B; Abivardi A; Avram M; Brandl F; Sorg C; Homan P; Riecher-Rössler A; Borgwardt S; Seifritz E; Dagher A; Kaiser S. Schizophrenia Bulletin. 2021.

Personalized Estimates of Brain Structural Variability in Individuals with Early Psychosis

Antoniades M.; Haas S.S.; Modabbernia A.; Bykowsky O.; Frangou S.; Borgwardt S.; Schmidt A.. Schizophrenia bulletin. 2021.

Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: A systematic review.

Mackintosh AJ; de Bock R; Lim Z; Trulley VN; Schmidt A; Borgwardt S; Andreou C. Neuroscience and biobehavioral reviews. 2021.

Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis

Schmidt A.; Davies C.; Paloyelis Y.; Meyer N.; De Micheli A.; Ramella-Cravaro V.; Provenzani U.; Aoki Y.; Rutigliano G.; Cappucciati M.; Oliver D.; Murguia S.; Zelaya F.; Allen P.; Shergill S.; Morrison P.; Williams S.; Taylor D.; Borgwardt S.; Yamasue H.; McGuire P.; Fusar-Poli P.. Translational Psychiatry. 2020.

Anatomical integrity within the inferior fronto-occipital fasciculus and semantic processing deficits in schizophrenia spectrum disorders.

Surbeck W; Hänggi J; Scholtes F; Viher PV; Schmidt A; Stegmayer K; Studerus E; Lang UE; Riecher-Rössler A; Strik W; Seifritz E; Borgwardt S; Quednow BB; Walther S. Schizophrenia research. 2020.

Excessive Exercise-A Meta-Review.

Colledge F; Cody R; Buchner UG; Schmidt A; Pühse U; Gerber M; Wiesbeck G; Lang UE; Walter M. Frontiers in Psychiatry. 2020.

Implementing MR Imaging into Clinical Routine Screening in Patients with Psychosis?

Schmidt A; Borgwardt S. NEUROIMAGING CLINICS OF NORTH AMERICA. 2020.

Ketamine Affects Prediction Errors about Statistical Regularities: A Computational Single-Trial Analysis of the Mismatch Negativity.

Weber LA; Diaconescu AO; Mathys C; Schmidt A; Kometer M; Vollenweider F; Stephan KE. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2020.

The genetic architecture of human brainstem structures and their involvement in common brain disorders.

Elvsåshagen T; Bahrami S; van der Meer D; Agartz I; Alnæs D; Barch DM; Baur-Streubel R; Bertolino A; Beyer MK; Blasi G; Borgwardt S; Boye B; Buitelaar J; Bøen E; Celius EG; Cervenka S; Conzelmann A; Coynel D; Di Carlo P; Djurovic S; Eisenacher S; Espeseth T; Fatouros-Bergman H; Flyckt L; Franke B; Frei O; Gelao B; Harbo HF; Hartman CA; Håberg A; Heslenfeld D; Hoekstra PJ; Høgestøl EA; Jonassen R; Jönsson EG; Karolinska Schizophrenia Project (KaSP) consortium.; Kirsch P; Kłoszewska I; Lagerberg TV; Landrø NI; Le Hellard S; Lesch KP; Maglanoc LA; Malt UF; Mecocci P; Melle I; Meyer-Lindenberg A; Moberget T; Nordvik JE; Nyberg L; Connell KSO; Oosterlaan J; Papalino M; Papassotiropoulos A; Pauli P; Pergola G; Persson K; de Quervain D; Reif A; Rokicki J; van Rooij D; Shadrin AA; Schmidt A; Schwarz E; Selbæk G; Soininen H; Sowa P; Steen VM; Tsolaki M; Vellas B; Wang L; Westman E; Ziegler GC; Zink M; Andreassen OA; Westlye LT; Kaufmann T. Nature Communications. 2020.

Association of antidepressants with brain morphology in early stages of psychosis: an imaging genomics approach.

Bykowsky O; Harrisberger F; Schmidt A; Smieskova R; Hauke DJ; Egloff L; Riecher-Rössler A; Fusar-Poli P; Huber CG; Lang UE; Andreou C; Borgwardt S. Scientific Reports. 2019.

Cross-Validation of Paranoid-Depressive Scale and Functional MRI: New Paradigm for Neuroscience Informed Clinical Psychopathology.

Stoyanov D; Kandilarova S; Arabadzhiev Z; Paunova R; Schmidt A; Borgwardt S. Frontiers in Psychiatry. 2019.

Negative affect moderates the effect of social rejection on frontal and anterior cingulate cortex activation in borderline personality disorder.

Wrege JS; Ruocco AC; Euler S; Preller KH; Busmann M; Meya L; Schmidt A; Lang UE; Borgwardt S; Walter M. Cognitive, affective & behavioral neuroscience. 2019.

No associations between medial temporal lobe volumes and verbal learning/memory in emerging psychosis.

Egloff L; Lenz C; Studerus E; Heitz U; Harrisberger F; Smieskova R; Schmidt A; Leanza L; Andreou C; Borgwardt S; Riecher-Rössler A. The European journal of neuroscience. 2019.

Subtle white matter alterations in schizophrenia identified with a new measure of fiber density.

Stämpfli P; Sommer S; Manoliu A; Burrer A; Schmidt A; Herdener M; Seifritz E; Kaiser S; Kirschner M. Scientific Reports. 2019.

Acute Effects of Glucose and Fructose Administration on the Neural Correlates of Cognitive Functioning in Healthy Subjects: A Pilot Study.

Zanchi D; Meyer-Gerspach AC; Schmidt A; Suenderhauf C; Depoorter A; Drewe J; Beglinger C; Wölnerhanssen BK; Borgwardt S. Frontiers in Psychiatry. 2018.

Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing.

Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S. International Journal of Neuropsychopharmacology. 2018.

Acute LSD effects on response inhibition neural networks

Schmidt A.; Muller F.; Lenz C.; Dolder P.C.; Schmid Y.; Zanchi D.; Lang U.E.; Liechti M.E.; Borgwardt S.. Psychological medicine. 2018.

Altered network hub connectivity after acute LSD administration

Muller F.; Dolder P.C.; Schmidt A.; Liechti M.E.; Borgwardt S.. NeuroImage-Clinical. 2018.

Disorganized gyrification network properties during the transition to psychosis

Das T.; Borgwardt S.; Hauke D.J.; Harrisberger F.; Lang U.E.; Riecher-Rossler A.; Palaniyappan L.; Schmidt A.. JAMA psychiatry. 2018.

Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes.

Rosburg T; Schmidt A. Frontiers in Behavioral Neuroscience. 2018.

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or with Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

Koutsouleris N.; Kambeitz-Ilankovic L.; Ruhrmann S.; Rosen M.; Ruef A.; Dwyer D.B.; Paolini M.; Chisholm K.; Kambeitz J.; Haidl T.; Schmidt A.; Gillam J.; Schultze-Lutter F.; Falkai P.; Reiser M.; Riecher-Rossler A.; Upthegrove R.; Hietala J.; Salokangas R.K.R.; Pantelis C.; Meisenzahl E.; Wood S.J.; Beque D.; Brambilla P.; Borgwardt S.. JAMA psychiatry. 2018.

Sexually dimorphic subcortical brain volumes in emerging psychosis

Egloff L.; Lenz C.; Studerus E.; Harrisberger F.; Smieskova R.; Schmidt A.; Huber C.; Simon A.; Lang U.E.; Riecher-Rossler A.; Borgwardt S.. Schizophrenia research. 2018.

Structural cortical network reorganization associated with early conversion to multiple sclerosis.

Tur C; Eshaghi A; Altmann DR; Jenkins TM; Prados F; Grussu F; Charalambous T; Schmidt A; Ourselin S; Clayden JD; Wheeler-Kingshott CAMG; Thompson AJ; Ciccarelli O; Toosy AT. Scientific Reports. 2018.

Implementing magnetic resonance imaging into clinical routine screening in patients with psychosis?

Borgwardt S.; Schmidt A.. The British journal of psychiatry : the journal of mental science. 2017.

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation

Schmidt A.; Cappucciati M.; Radua J.; Rutigliano G.; Rocchetti M.; Dell'Osso L.; Politi P.; Borgwardt S.; Reilly T.; Valmaggia L.; McGuire P.; Fusar-Poli P.. Schizophrenia bulletin. 2017.

Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.

Schmidt A; Antoniades M; Allen P; Egerton A; Chaddock CA; Borgwardt S; Fusar-Poli P; Roiser JP; Howes O; McGuire P. Psychological medicine. 2017.

ABERRANT SALIENCE, HIPPOCAMPAL ACTIVATION, AND SUBCORTICAL DOPAMINE FUNCTION IN PEOPLE AT ULTRA HIGH RISK FOR PSYCHOSIS

SCHMIDT, ANDRE; WINTON-BROWN, TOBY; KAPUR, SHITIJ; ROISER, JON; HOWES, OLIVER; EGERTON, ALICE; GRACE, TONY; STONE, JAMES; MCGUIRE, PHILIP. . 2016.

Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

Fusar-Poli P; Rutigliano G; Stahl D; Schmidt A; Ramella-Cravaro V; Hitesh S; McGuire P. JAMA psychiatry. 2016.

Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis.

Schmidt A; Palaniyappan L; Smieskova R; Simon A; Riecher-Rössler A; Lang UE; Fusar-Poli P; McGuire P; Borgwardt SJ. Journal of psychiatry & neuroscience : JPN. 2016.

Is neuroimaging clinically useful in subjects at high risk for psychosis?

Borgwardt S; Schmidt A. World psychiatry : official journal of the World Psychiatric Association (WPA). 2016.

The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.

Kraehenmann R; Schmidt A; Friston K; Preller KH; Seifritz E; Vollenweider FX. NeuroImage-Clinical. 2016.

Approaching a network connectivity-driven classification of the psychosis continuum: A selective review and suggestions for future research

Schmidt A.; Diwadkar V.A.; Smieskova R.; Harrisberger F.; Lang U.E.; McGuire P.; Fusar-Poli P.; Borgwardt S.. Frontiers in Human Neuroscience. 2015.

Brain Diffusion Changes in Emerging Psychosis and the Impact of State-Dependent Psychopathology

Schmidt A.; Lenz C.; Smieskova R.; Harrisberger F.; Walter A.; Riecher-Rossler A.; Simon A.; Lang U.E.; McGuire P.; Fusar-Poli P.; Borgwardt S.J.. Neuro-Signals. 2015.

Dissociable behavioral, physiological and neural effects of acute glucose and fructose ingestion: A pilot study

Wolnerhanssen B.K.; Meyer-Gerspach A.C.; Schmidt A.; Zimak N.; Peterli R.; Beglinger C.; Borgwardt S.. PLoS One. 2015.

Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution

Schmidt A.; Denier N.; Magon S.; Radue E.-W.; Huber C.G.; Riecher-Rossler A.; Wiesbeck G.A.; Lang U.E.; Borgwardt S.; Walter M.. Translational Psychiatry. 2015.

Ventral striatal activation during reward processing in psychosis a neurofunctional meta-analysis

Radua J.; Schmidt A.; Borgwardt S.; Heinz A.; Schlagenhauf F.; McGuire P.; Fusar-Poli P.. JAMA psychiatry. 2015.

Abnormal effective connectivity and psychopathological symptoms in the psychosis high-risk state.

Schmidt A; Smieskova R; Simon A; Allen P; Fusar-Poli P; McGuire PK; Bendfeldt K; Aston J; Lang UE; Walter M; Radue EW; Riecher-Rössler A; Borgwardt SJ. Journal of psychiatry & neuroscience : JPN. 2014.

Altered prefrontal connectivity after acute heroin administration during cognitive control.

Schmidt A; Borgwardt S; Gerber H; Schmid O; Wiesbeck GA; Riecher-Rössler A; Bendfeldt K; Smieskova R; Lang UE; Rubia K; Walter M. International Journal of Neuropsychopharmacology. 2014.

Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder.

Dauvermann MR; Whalley HC; Schmidt A; Lee GL; Romaniuk L; Roberts N; Johnstone EC; Lawrie SM; Moorhead TW. Frontiers in Psychiatry. 2014.

Effects of cannabis on impulsivity: A systematic review of neuroimaging findings

Wrege J.; Schmidt A.; Walter A.; Smieskova R.; Bendfeldt K.; Radue E.-W.; Lang U.E.; Borgwardt S.. Current pharmaceutical design. 2014.

Green tea extract enhances parieto-frontal connectivity during working memory processing

Schmidt A.; Hammann F.; Wolnerhanssen B.; Meyer-Gerspach A.C.; Drewe J.; Beglinger C.; Borgwardt S.. Psychopharmacology. 2014.

Neuropsychopharmacology of psychosis: Relation of brain signals, cognition, and chemistry

Schmidt A.; Borgwardt S.. Frontiers in Psychiatry. 2014.

Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.

Bernasconi F; Schmidt A; Pokorny T; Kometer M; Seifritz E; Vollenweider FX. Cerebral cortex (New York, N.Y. : 1991). 2014.

ABNORMAL BRAIN FUNCTIONING DURING SALIENCE PROCESSING IN PATIENTS WITH SCHIZOPHRENIC PSYCHOSIS

WALTER, A.; SMIESKOVA, R.; SCHMIDT, A.; SIMON, A.; VOGEL, T.; ROISER, J. P.; RIECHER-ROESSLER, A.; BORGWARDT, S.. . 2013.

Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations.

Kometer M; Schmidt A; Jäncke L; Vollenweider FX. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2013.

Brain connectivity abnormalities predating the onset of psychosis: Correlation with the effect of medication

Schmidt A.; Smieskova R.; Aston J.; Simon A.; Allen P.; Fusar-Poli P.; McGuire P.K.; Riecher-Rossler A.; Stephan K.E.; Borgwardt S.. JAMA psychiatry. 2013.

Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities.

Smieskova R; Marmy J; Schmidt A; Bendfeldt K; Riecher-Rӧssler A; Walter M; Lang UE; Borgwardt S. Current Medicinal Chemistry. 2013.

EFFECT OF CURRENT ANTIPSYCHOTIC MEDICATION ON ADAPTIVE SALIENCE PROCESSING IN FIRST-EPISODE OF PSYCHOSIS INDIVIDUALS

SMIESKOVA, R.; ROISER, J.; CHADDOCK, C. H.; SCHMIDT, A.; BORGWARDT, S.. . 2013.

Inferior frontal cortex modulation with an acute dose of heroin during cognitive control

Schmidt A.; Walter M.; Gerber H.; Schmid O.; Smieskova R.; Bendfeldt K.; Wiesbeck G.A.; Riecher-Rossler A.; Lang U.E.; Rubia K.; McGuire P.; Borgwardt S.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2013.

INHIBITION-SPECIFIC PREFRONTAL CONNECTIVITY AFTER AN ACUTE DOSE OF HEROIN

SCHMIDT, A.; BORGWARDT, S.; SCHMID, O.; WIESBECK, G. A.; RIECHER-ROESSLER, A.; BENDFELDT, K.; SMIESKOVA, R.; LANG, U. E.; RUBIA, K.; WALTER, M.. . 2013.

Modeling ketamine effects on synaptic plasticity during the mismatch negativity.

Schmidt A; Diaconescu AO; Kometer M; Friston KJ; Stephan KE; Vollenweider FX. Cerebral cortex (New York, N.Y. : 1991). 2013.

Molecular bases of antipsychotic drugs: the contribution of neurosciences.

Borgwardt S; Schmidt A. Current Medicinal Chemistry. 2013.

THE EFFECT OF THE BRAIN-DERIVED NEUROTROPHIC FACTOR VAL66MET POLYMORPHISM ON HUMAN HIPPOCAMPAL VOLUME - META-ANALYSIS

HARRISBERGER, F.; SMIESKOVA, R.; SCHMIDT, A.; PAPASSOTIROPOULOS, A.; BORGWARDT, S.. . 2013.

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.

Schmidt A; Kometer M; Bachmann R; Seifritz E; Vollenweider F. Psychopharmacology. 2013.

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2012.

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.

Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX. Biological psychiatry. 2012.